Cephalon, Inc. · Frazer, PA United States ·(NASDAQ (GS): CEPH)
Company Description
View Cephalon, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Cephalon isn't asleep at the wheel. The company sells PROVIGIL, a treatment for the sleep disorder narcolepsy, in the US and select countries around the world. The company's other top sellers are cancer pain medications ACTIQ and FENTORA, epilepsy treatment GABITRIL (licensed from Abbott Labs and Novo Nordisk ), and cancer drug TREANDA. It sells seven products in the US and has more than a dozen approved drugs on the market in Europe. Cephalon's drug research and development activities focus on central nervous system disorders, cancer, and pain. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Cephalon, Inc. Financials
| Company Type | Public - NASDAQ (GS): CEPH Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $1,974.6 |
| 2008 Employees | 2,780 |
Cephalon, Inc. Executives
35 executives listed for Cephalon, Inc.'s Frazer, PA location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Frank Baldino | Network |
| EVP and CFO | J. Kevin Buchi | Network |
| EVP Worldwide Technical Operations | Peter Grebow | Network |
Competition
Competitive Landscape for Cephalon, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Cephalon, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!